John Goldman Fellowships 2024 (United Kingdom)

Research Scope

• The proposed research must have relevance to leukaemia and/or related diseases. Translational projects are particularly encouraged. Fellowships are designed to enable talented research scientists/clinician-scientists to test a novel hypothesis and get their research and careers off the ground in a supportive, well-funded environment, so that they can pursue their work creatively.
• Successful applicants must be able to demonstrate:
  • An innovative idea
  • Scientific excellence
  • The potential for success

Funding Information

• Continued investment
  • Grants are for up to £150k maximum, to span a minimum duration of 18 months and maximum duration of two years. Potential to utilise the grant to leverage additional or matched funding will be viewed favourably but is not essential. The grant may be used for salary and direct costs of the project, but it will not support indirect costs such as institutional overheads.
  • The initial application should provide indicative financial information as to how the award will be utilised, corroborated by the relevant finance department.
• Olive Boles Innovation Award
  • The Olive Boles Innovation Award was launched in 2021 and is given to one fellowship awardee each year. This accolade is given in recognition of an innovative, higher-risk idea that could contribute significantly to the understanding of leukaemia. The awardee is selected as part of the normal peer review process, and is awarded a combined Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award.

Eligibility Criteria

• Relevant, high quality and feasible applications are invited from research scientists and clinicianscientists from across the UK. There is no age limit, although the awards are designed to provide an opportunity for talented early career scientists to develop as independent investigators.
• Awards are open to researchers (who may or may not be medically qualified) who can demonstrate genuine potential to become the leading scientists of the future. Applicants should have a good publication record, but it does not need to be exceptional at this stage.
• The John Goldman Fellowships are aimed at three main categories of applicant:
  • Principal Investigators (PI) within two years of first permanent appointment.
  • Post-doctoral researchers in the process of gaining PI status. Full explanation of path to full PI status should be provided. Normally expected to have completed one post-doctoral position but be within six years of having obtained a PhD, although exceptions will be considered if clearly justified.
  • Clinician scientists with no more than six years post-PhD experience, although exceptions will be considered.

For more information, visit Leukaemia UK.